Article Details
Retrieved on: 2021-08-04 14:37:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Zymergen said it had about $588 million in remaining cash and equivalents and plans to cut expenses in light of the forecasted drought in revenue ...
Article found on: www.fiercebiotech.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here